Moderator

• 

• Justin F. Gainor, MD

  Associate Professor
  Department of Medicine
  Harvard Medical School
  Director
  Center for Thoracic Cancers Program
  Director
  Targeted Immunotherapy
  Massachusetts General Hospital
  Boston, Massachusetts, United States

  Disclosures

  Justin F. Gainor, MD, has the following relevant financial relationships:
  Consultant or advisor for: AI Proteins; AstraZeneca Pharmaceuticals LP; Blueprint Medicine; Bristol Myers Squibb Company; Curie Therapeutics; Genentech/Roche; Gilead Sciences, Inc.; iTeos; Karyopharm; Loxo Oncology/Lilly; Moderna, Inc.; Mirati; Merck; Merus; Novartis; Nuvalent; Pfizer, Inc.; Silverback Therapeutics; Takeda
  Speaker or member of speakers bureau for: Pfizer, Inc.
  Research funding from: Adaptimmune; Alexo; Array BioPharma; Blueprint Medicine; Bristol Myers Squibb Company; Genentech/Roche; Jounce Therapeutics; Merck; Moderna, Inc.; Novartis; Palleon
  Owns stock (privately owned) in: AI Proteins

Faculty

• 

• Benjamin Solomon, MBBS, PhD

  Professor and Medical Oncologist
  Department of Medical Oncology
  Peter MacCallum Cancer Centre
  Sir Peter MacCallum Department of Oncology
  University of Melbourne
  Melbourne, Australia

  Disclosures

  Benjamin Solomon, MBBS, PhD, has the following relevant financial relationships:
  Consultant or advisor for: Amgen, Inc.; AstraZeneca Pharmaceuticals LP; BeiGene (Beijing) Co., Ltd; Bristol Myers Squibb Company; Janssen Biotech, Inc.; Merck; Novartis; Pfizer, Inc.; Roche; Takeda
  Speaker or member of speakers bureau for: Amgen, Inc.; AstraZeneca Pharmaceuticals LP; BeiGene (Beijing) Co., Ltd; Bristol Myers Squibb Company; Eli Lilly and Company; Novartis; Pfizer, Inc.; Roche; Sanofi

• 

• Rasheda A. Persinger, AGNP-C, AOCNP

  Medical Oncology Lead Nurse Practitioner
  Johns Hopkins Sidney Kimmel Cancer Center
  Sibley Memorial Hospital
  Washington, DC, United States

  Disclosures

  Participation by Dr Rasheda A. Persinger, AGNP-C, AOCNP does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
  
  Rasheda A. Persinger, AGNP-C, AOCNP, has the following relevant financial relationships:
  Consultant or advisor for: Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Guardant Health, Inc.; Mirati
  Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP; Guardant Health, Inc.

Editor

• Eloise Ballard, PhD

  Scientific Content Manager, WebMD Global, LLC

  Disclosures

  Eloise Ballard, PhD, has no relevant financial relationships.

Compliance Reviewer

• Stephanie Corder, ND, RN, CHCP

  Associate Director, Accreditation and Compliance, Medscape, LLC

  Disclosures

  Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.